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An electrochemical method based on a directly electrochemically reduced graphene oxide (ERGO) ﬁlm
coated on a glassy carbon electrode (GCE) was developed for the rapid and convenient determination of
rutin in plasma. ERGO was modiﬁed on the surface of GCE by one-step electro-deposition method.
Electrochemical behavior of rutin on ERGO/GCE indicated that rutin underwent a surface-controlled
quasi-reversible process and the electrochemical parameters such as charge transfer coefﬁcient (α),
electron transfer number (n) and electrode reaction standard rate constant (ks) were 0.53, 2 and 3.4 s
1,
respectively. The electrochemical sensor for rutin in plasma provided a wide linear response range of
4.701071.25105 M with the detection limit (s/n¼3) of 1.84108 M. The assay was success-
fully used to the pharmacokinetic study of rutin. The pharmacokinetic parameters such as elimination
rate half-life (t1/2), area under curve (AUC), and plasma clearance (CL) were calculated to be
3.34570.647 min, 57507656.0 mg min/mL, and 5.89170.458 mL/min/kg, respectively. The proposed
method utilized a small sample volume of 10 μL and had no complicated sample pretreatment (without
deproteinization), which was simple, eco-friendly, and time- and cost-efﬁcient for rutin pharmacokinetic
studies.
& 2015 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Rutin (3′, 4′, 5, 7-tetrahydroxy-ﬂavone-3-rutinoside) [1], the
glycoside between the ﬂavonol quercetin and the disaccharide
rutinose, is a common dietary ﬂavonoid that is consumed in fruits,
vegetables and plant-derived beverages such as tea and wine [2].
Some related investigations show that rutin exhibits a broad range
of physiological activities, such as anti-inﬂammation [3], anti-tu-
mor [4], immunoregulation [5], antioxidation [6] and anti-de-
pression [7]. So it is often used as a therapeutical drug. However,
quercetin, the metabolite of rutin, has been identiﬁed in the blood
of animals following administration of rutin [8]. Hence, it is ne-
cessary to develop some simple, economical and efﬁcient methods
for the determination of rutin and distinguish it from quercetin in
biological samples.
Numerous analytical techniques have been developed to
quantify rutin in plasma, including high performance liquidon and hosting by Elsevier B.V. Th
University.chromatography (HPLC) [9], liquid chromatography–mass spec-
trometry (LC–MS) [10], solid phase extraction-high performance
liquid chromatography-diode array detection (SPE–HPLC–DAD)
[11] and ultra performance liquid chromatography–electrospray
ionization–tandem mass spectrometry (UPLC–ESI–MS/MS) [12],
and the limit of detection (LOD) is in the range of 1–10 ng/mL.
However, the drawback of these methods is that large plasma
volume (0.2–1.0 mL) is required. To minimize the volume of blood
sampling, drug assays requiring smaller sample volumes are es-
sential. Moreover, these methods have another drawback of
complicated sample extraction process which limits the ease of
their use [13,14]. Sample pretreatment often needs high-purity
organic solvents and nitrogen evaporation step, which are time-
consuming and environmental-unfriendly [15].
Compared with these methods, electrochemical methods have
been proven to be a powerful tool to get rutin information in
complex samples due to their high sensitivity, easy operation and
low sample volume [16,17]. Previous studies have investigated the
electrochemical behavior of rutin and achieved quantitative de-
termination of rutin using several working electrodes such as
multi-wall carbonnanotube paste electrode [18], β-cyclodextrin
incorporated carbon nanotube-modiﬁed electrode [19], a sensoris is an open access article under the CC BY-NC-ND license
P. Zhang et al. / Journal of Pharmaceutical Analysis 6 (2016) 80–86 81based on β-cyclodextrin@chemically reduced graphene/naﬁon
composite ﬁlm [20], acetylene black nanoparticles-modiﬁed elec-
trode [21], grapheme modiﬁed carbon ionic liquid electrode [22],
and graphene nanosheets modiﬁed glassy carbon electrode [23].
The performance of the modiﬁed electrodes depends on the
properties of the modiﬁers that affect the selectivity and sensi-
tivity of these electrodes to rutin.
Graphene has attracted tremendous attention in the past
several years after its ﬁrst isolation [24]. It exhibits great promises
in various aspects owing to its unique properties such as high
electron mobility [25], excellent mechanical strength [26], out-
standing thermal conductivity [27] and large speciﬁc surface area
[28,29]. Nowadays, a novel method, preparing graphene by elec-
trochemical reduction of the exfoliated graphene oxide (GO), has
and garnered particular attention. The electrochemically reduced
graphene oxide (ERGO) to reduced graphene oxide (RGO) [30,31],
as an alternative to chemical, photocatalytic, and thermal reduc-
tion techniques, can be a simple, economic, and environmentally
friendly method. And graphene ﬁlms with desirable thickness can
be fabricated on electrode substrates by adjusting the electrode
potential [3,32].
Based on these, this study developed an electrochemical
method based on ERGO to facilitate pharmacokinetic studies of
rutin. The electrochemical behavior of rutin on ERGO/GCE was
investigated and the values of pH and accumulation time were
optimized. Then ERGO/GCE was applied to determine rutin in
10 μL of plasma obtained from rats after intravenous administra-
tion of rutin. The pharmacokinetic parameters were calculated. For
comparison, these results were validated by HPLC. The procedure
is shown in Scheme 1.Scheme 1. The preparation of ERGO/GCE and its applic2. Materials and methods
2.1. Reagents
Graphite powder (KS-10, 99.5%) was from Sigma (USA). 0.2 M
phosphate buffer solution (PBS) was prepared by Na2HPO4 and
NaH2PO4. Acetonitrile of HPLC grade was purchased from Ocean-
pak (Sweden). Ultrapure water was generated from the Milli-Q
system (Millipore, Bedford, MA, USA). All other reagents were of
analytical grade.
2.2. Apparatus
All electrochemical measurements were carried out on a CHI
1220A electrochemical workstation (Shanghai CH Instrument,
China). A three-electrode system was employed with a bare or
modiﬁed GCE as the working electrode, a platinumwire (Pt) as the
counter electrode, and a saturated calomel electrode (SCE) as the
reference electrode. The pH measurement was performed via a
pHs-3B digital pH-meter (Shanghai Precision Scientiﬁc Instru-
ment, China).
2.3. Preparation of graphene oxide and fabrication of the modiﬁed
electrodes
Graphite oxide (GO) was prepared from graphite powder by a
modiﬁed method reported by Hummers and Offeman [33]. Pre-
paration of graphene oxide and fabrication of the modiﬁed elec-
trodes were performed as described in our previous paper [34]. In
brief, before modiﬁcation, the bare GCE was ﬁrst polished to a
mirror-like surface with 0.3 μm and 0.05 μm of alumina slurry and
then sonicated for 1 min in methanol and water successively. After
the surface was dried by nitrogen, exfoliated GO (3 mg/mL) wasation to the pharmacokinetic study of rutin in rats.
Fig. 1. CVs of ERGO/GCE (a) without rutin, and bare GCE (b), and ERGO/GCE
(c) with 2.0105 M rutin in 0.2 M PBS (pH 3.0) at 100 mV/s.
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1.2 V for 200 s by a CHI 1220A electrochemical workstation
under computer control to obtain the ERGO/GCE.
2.4. Plasma samples preparation
Six male Wistar rats weighing 220–260 g were acquired from
the Experimental Animal Center of Lanzhou University (Lanzhou,
China). Following intravenous administration of rutin via caudal
vein at the dose of 26.67 mg/kg, blood samples were collected via
the fossa vein orbitalis into the heparinized microcentrifuge tubes
at 2.5, 5.0, 7.5, 10.0, 12.5, 15.0, 20.0, 30.0, 60.0, and 120.0 min, and
centrifuged. The supernatant was collected and stored at 20 °C
until analysis.
A series of rutin alcohol solutions were added to the blank
plasma, and the mixed samples were stirred and vibrated for
2 min, and then centrifuged. The supernatant was collected and
stored at 20 °C for establishing the calibration curve.
2.5. Electrochemical measurements
Electrochemical behavior of rutin on ERGO/GCE was recorded
by cyclic voltammetry (CV) from 0.2 V to 0.8 V in PBS at a scan
rate of 100 mV/s. Under the optimal conditions, the prepared
electrodes were ﬁrst immersed in the PBS containing rutin plasma
for 9 min. Next, differential pulse voltammetry (DPV) was re-
corded from 0.2 V to 0.8 V at a scan rate of 100 mV/s.
2.6. Validation by HPLC
HPLC measurements were carried out on a Waters Alliance
2695 HPLC system (America) equipped with a 2998 Photo-Diode
Array. Chromatographic separations were performed using a Dia-
monsil C18 (250 mm4.6 mm, 5 μm), connected with a C18 guard
column (10 mm4.6 mm, 5 μm). A linear gradient elution of
eluent A (acetonitrile) and B (0.5% acetic acid; v/v) was used for
the separation. The elution program was performed as follows:
19% A at 0–10 min, 19%–50% A at 10–20 min, 50%–80% A at 20–
30 min, and 80%–100% A at 30–40 min.3. Results and discussion
3.1. Characterization of ERGO/GCE
The morphology and microstructure of the modiﬁed electrodes
were characterized by scanning electron microscopy (SEM) and
Raman spectroscopy. The SEM image of ERGO/GCE showed that a
few layers of ERGO were partially packed with their basal planes,
intensely crumpled, and folded into a typical wrinkled structure
after electrochemical reduction occurred. The corrugations in
ERGO can cause electron transfer rates 10-fold faster than those at
the basal plane of graphite. Raman spectra showed that the bands
of ERGO were strongly strengthened compared with those of GO,
indicating the restored ordered crystal structure of ERGO and the
smaller sp2 domains in ERGO sheets. As a result, the commu-
nication between the ERGO-active electrode and the redox species
was improved [34].
3.2. Electrochemical behavior of rutin
The electrochemical responses of rutin on bare GCE and ERGO/
GCE were examined using CV in PBS at pH 3.0. As shown in Fig. 1,
no redox peaks were observed on ERGO/GCE in the blank PBS
(curve a), indicating that the proposed sensor was non-electro-
active in the selected scanning potential region. After a certainamount of rutin was added into the blank PBS, the bare GCE (curve
b) showed a pair of relatively poor redox peaks at 0.466 V and
0.482 V while the redox peaks currents of ERGO/GCE signiﬁcantly
increased (curve c). These results may be attributed to ERGO, as
ERGO can provide a large speciﬁc surface area to increase the
loading amount of rutin on the electrode surface. Meanwhile,
ERGO can also accelerate the electron transfer rate on electrode
surface and amplify the electrochemical signals as a result of its
effective electrical conductivity.
3.3. Optimization of experimental conditions
3.3.1. Inﬂuence of pH
The inﬂuence of pH on the cyclic voltammetric responses of
1.0105 M rutin on ERGO/GCE was investigated in the pH range
from 2.0 to 8.0 with the voltammograms (Fig. 2A). It could be seen
that a pair of well-deﬁned redox peaks appeared and the redox
peaks potentials shifted to the negative direction with the increase
of buffer pH, indicating that protons took part in the electrode
reaction. The redox peaks potentials (E0′) changed linearly with pH
values from 2.0 to 8.0 (inset of Fig. 2A), and the linear regression
equation was E0′ (V)¼ 0.0562 pHþ0.6544 with R2¼0.9982. The
slope of 0.0562 V/pH was close to theoretical value of 0.059 V/
pH, indicating that the ratio of electrons and protons involved in
the electrochemical reaction was 1:1. The peaks currents increased
until pH 3.0 and then decreased. However, when the pH was over
7.0, the redox peaks became very small. These experimental phe-
nomena were related to the protons involved in the electro-
chemical reaction. Therefore, pH 3.0 was selected as the optimal
pH for detection in the following experiments.
3.3.2. Inﬂuence of scan rate
Useful information usually can be acquired from the relation-
ship between the peaks currents and scan rates. CVs of ERGO/GCE
were applied to study the electrochemical mechanism in PBS
containing 1.0105 M rutin at different scan rates. The redox
peaks currents increased with the increase of scan rates in the
range of 20–900 mV/s (Fig. 2B), accompanied with the shift of the
redox peaks potentials. Both the cathodic and anodic peaks cur-
rents of rutin were linearly proportional to the scan rates ranging
from 20 mV/s to 900 mV/s. The regression equations were Ipa
(μA)¼0.0207 v (mV/s)þ0.9552 and Ipc (μA)¼0.0165 v (mV/s)
 0.6178 with R2¼0.9845 and 0.9840, respectively, which in-
dicated an adsorption controlled electrode process.
In addition, as shown in Fig. 2C, at the high scan rates, the
Fig. 2. (A) CVs of ERGO/GCE in PBS containing 1.0105 M of rutin with different pH values (2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0). (a) Plot of peaks currents of rutin (Ip) vs pH.
(b) The linear relationship between the anodic peaks potentials and pH. (B) CVs of 1.0105 M rutin on ERGO/GCE with different scan rates (20, 40, 100, 200, 300, 400, 500,
600, 700, 800, 900 mV/s, respectively) in PBS. Inset shows linear relationship between scan rates (v) and redox peaks currents (Ip). (C) Linear relationship between the redox
peaks potentials (Ep) and lgv. (D) The relationship between accumulation time (t) and peaks currents (Ip).
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with the linear regression equations as follows: Epa (V)¼
0.0554lgν (V/s)þ0.5162 and Epc (V)¼0.0486lgν (V/s)þ0.4354
with R2¼0.9835 and 0.9875, respectively. According to Laviron’s
equations [35],
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where α is the charge transfer coefﬁcient, n is the electron transfer
number, ks is the electrode reaction standard rate constant, R is the
gas constant, T is the absolute temperature, and ΔEp is the peak-
to-peak separation. The value of α, n and ks were calculated as
0.53, 2 and 3.4 s1, respectively. Hence, the electro-oxidation re-
action of rutin on the ERGO/GCE was a two-electron two-proton
process, which was in agreement with Ref. [20].
3.3.3. Inﬂuence of accumulation time
Accumulation can improve the amount of rutin adsorbed on
the electrode surface, and then improve determination sensitivity
and decrease detection limit. Thus, the effect of the accumulationtime on the proposed electrode response was investigated for
1.0105 M rutin in 0.2 M PBS at pH 3.0. As shown in Fig. 2D, the
peaks currents increased gradually from 0 min to 9 min, and then
were almost constant. The peaks currents increased with the ac-
cumulation time because more rutin was adsorbed on the elec-
trode surface. The peaks currents kept constant after 9 min, which
could be explained by the saturated adsorption of rutin on the
electrode surface. Therefore, 9 min was employed as the optimal
accumulation time.
3.4. Method validation
3.4.1. Matrix effect
The feasibility of the method was evaluated by comparing the
DPV curves of different plasma samples. As depicted in Fig. 3A, in
the absence of rutin, no current peaks could be observed in PBS
(curve a) while a current peak appeared at 0.50 V in the potential
window after the addition of the blank plasma (curve b). In the
presence of rutin standard solution (curve c), plasma spiked with
rutin (curve d) or actual plasma sample (curve e), well-deﬁned
peaks at the peak potentials of 0.45 V were observed, which was
ascribed to the redox reaction of rutin. From the results above, we
concluded that there was a weak endogenous peak at 0.50 V in
blank plasma, but it did not interfere the determination of rutin. In
order to further verify whether the sensor could distinguish rutin
from quercetin (the metabolism of rutin) or not, the spiked quer-
cetin plasma (curve f) was investigated and the current peak ap-
peared at 0.36 V, which was different from that of rutin. Thus, the
Fig. 3. (A) DPV of rutin in different matrices on ERGO/GCE (a. PBS. b. blank plasma. c. rutin standard solution. d. spiked rutin plasma. e. actual plasma sample obtained from
rat after intravenous administration of rutin. f. spiked quercetin plasma). (B) DPV of ERGO/GCE in PBS (0.2 M, pH 3.0) with various concentrations of spiked rutin plasma
solutions. Inset: concentration calibration curve of the DPV currents response for rutin. (C) DPV of ERGO/GCE in PBS (0.2 M, pH 3.0) containing plasma samples that were
obtained at different time (2.5, 5.0, 7.5, 10.0, 12.5, 15.0, 20.0 min) from rats after intravenous administration of rutin. (D) Mean plasma concentration–time curves of rutin in
rats determined by ERGO/GCE (curve a) and HPLC (curve b) (n¼6).
Table 1
Comparison of electrochemical methods for rutin detection.
Electrodes Linear range (M) Detection limit
(M)
Refs.
MWNTs/β-CD 4.0107–1.0103 2.0107 [19]
CNTPE 1.0107–1.0108 4.0 l08 [18]
AB nanoparticle/GCE 3.1108–7.8106 1.5108 [21]
GR/CILE 7.0108–1.0104 2.4108 [22]
β-CD@CRG/Naﬁon/
GCE
6.0109–1.0105 2.0109 [20]
GNs/GCE 1.0107–1.0105 2.1108 [23]
GR-MnO2/CILE 1.0108–5.0104 2.7109 [36]
SWCNTs/Au electrode 2.0108–1.0106 1.0108 [37]
SWCNTs/CILE 1.0107–1.7106 7.0108 [38]
ERGO/GCE 4.7107–1.2105 1.8108 This
work
MWNTs: multi-walled carbon nanotubes. β-CD: β-cyclodextrin. CNTPE: multi-wall
carbonnanotube paste electrode. AB nanoparticle: acetylene black nanoparticle-
modiﬁed electrode. GCE: glassy carbon electrode. GR: grapheme. CILE: carbon ionic
liquid electrode. β-CD@CRG: β-cyclodextrin@chemically reduced grapheme. GNs:
graphene nanosheets. SWCNTs: single-walled carbon nanotube. ERGO: electro-
chemically reduced graphene oxide.
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rutin in plasma.
3.4.2. Calibration curve
To study the analytical performance of the obtained electro-
chemical sensor, DPV was explored for the amperometric re-
sponses of spiked rutin standard plasma solutions. Fig. 3B shows
the typical DPV obtained from different rutin concentrations. Un-
der the optimal conditions, the peaks currents had a good linear
relationship with rutin concentrations in the range of
4.70107–1.25105 M, as shown in the inset of Fig. 3B. The
linear regression equation was I (μA)¼0.258 c (μM)0.0759 with
R2¼0.9964. The detection limit (s/n¼3) was estimated at ap-
proximately 1.84108 M. The comparison of the analytical per-
formance of ERGO/GCE with other electrochemical methods [18–
23,36–38] for rutin determination is summarized and listed in
Table 1.
3.4.3. Reproducibility and speciﬁcity study
Six modiﬁed electrodes were fabricated independently, which
gave a satisfactory average relative standard deviation (RSD) value
of 3.90% for the detection of 1.0105 M rutin solution, indicating
the good reproducibility of the electrode fabrication. The speciﬁ-
city of the sensor was studied through the interference of some
foreign species on the determination of rutin under the optimized
conditions. PBS containing 1.0106 M rutin and different
quantities of interferents were prepared to record the DPV. Theresults are shown in Table 2. Under the existence of those inter-
ferents, the recoveries of rutin changed between 95.14% and
104.76%, which displayed the species caused no interference at
high concentrations.
Table 2
Interference of different species on rutin determination by ERGO/GCE.
Interferents Concentration (M) Recovery (%)
Naþ 1.005104 104.76
Kþ 1.005104 99.15
Cl 1.005104 99.15
SO42 1.005104 95.38
NO3 1.005104 95.14
Acetyl aminophenol 1.005104 97.45
Citric acid 1.005104 103.87
Glucose 1.005104 99.23
L-glutamic acid 5.025105 96.31
L-glycine 5.025105 95.65
Ascorbic acid 5.025105 102.49
Quercetin 1.507105 101.75
Puerarin 1.507105 102.13
Baicalin 1.507105 104.52
Dopamine 1.507105 104.21
Folic acid 1.507105 97.76
Table 3
Recovery of rutin detection in plasma using ERGO/GCE (n¼3).
No. Spiked amount (μg/mL) Detected amount (μg/mL) Recovery (%)
1 38.20 39.00 102.09
2 38.20 37.43 97.98
3 38.20 39.61 103.69
Average 38.20 38.68 101.25
Table 4
Intra-day and inter-day precision for rutin determination in plasma using ERGO/
GCE (Mean7SD, n¼3).
Added conc.
(μg/mL)
Intra-day Inter-day
Detected conc.
(μg/mL)
RSD (%) Detected conc.
(μg/mL)
RSD (%)
5.73 5.9570.35 5.96 5.5870.36 6.50
22.92 21.0070.46 2.20 20.1971.02 5.04
42.02 42.7270.90 2.11 44.5072.04 4.59
RSD: relative standard deviation.
Table 5
Pharmacokinetic parameters of rutin in rats after intravenous administration of
rutin determined by ERGO/GCE and HPLC (n¼6).
Pharmacokinetic parameter Methods
ERGO/GCE HPLC
Ke (min1) 0.22370.083 0.24070.062
t1/2 (min) 3.34570.647 2.88170.351
AUC (mg min/mL) 57507656.0 6294752.01
MRT (min) 1.36770.098 0.93470.082
Vd (mL/kg) 31.9070.864 17.6170.923
CL (mL/min/kg) 5.89170.458 4.23070.676
Ke: elimination rate constant.
t1/2: half-life of drug elimination during the terminal phase.
AUC: area under the plasma mean concentrations–time curve.
MRT: mean retention time.
Vd: volume of distribution.
CL: plasma clearance.
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The accuracy of this proposed method was evaluated by de-
termination of three parallel spiked rutin plasma solutions
(38.20 μg/mL). As shown in Table 3, the results were satisfactory
with the recovery varying from 97.98% to 103.69%, showing that
the proposed sensor could be efﬁciently applied to the detection of
rutin with good accuracy. The intra-day precision was estimated
by determining three spiked rutin plasma solutions (5.73, 22.92
and 42.02 μg/mL) with three replicate measurements in the same
run. The RSDs of the measurements were 5.96%, 2.20% and 2.11%,
respectively. Similarly, the RSDs of the inter-day precision were
6.50%, 5.04% and 4.59%, respectively (Table 4). Both the RSDs of
inter-day and intra-day precisions were less than 15%, indicating
that the prepared sensor was applied to determine rutin with a
sufﬁcient precision [12,39].
3.5. Pharmacokinetic study of rutin in rats
On the optimization of electrochemical parameters, determi-
nation of rutin in rat plasma samples (10 μL) was performed ac-
cording to the procedures for treatment of plasma samples and
electrochemistry measurement described in Sections 2.4 and 2.5.
As depicted in Fig. 3C, there were current peaks of rutin at 0.45 V
only in the plasma samples that were collected at 0–15 min afterinjection. In comparison, HPLC was employed to the determination
of rutin in actual plasma samples. The mean plasma concentra-
tion–time curves of rutin in plasma determined by ERGO/GCE
(curve a) and HPLC (curve b) are shown in Fig. 3D. The pharma-
cokinetic parameters were calculated using PKSOLN 2.0 and are
summarized in Table 5. There was no signiﬁcant difference be-
tween the results given by the two methods, that was, the pro-
posed method could be potentially useful for determination of
rutin in biological samples. Urine and feces samples were also
determined by ERGO/GCE or HPLC, but there was no rutin in these
samples.4. Conclusions
In the present study, a rapid and convenient electrochemical
method based on ERGO/GCE had been developed and fully vali-
dated for the pharmacokinetic study of rutin in plasma. The pro-
posed sensor displayed satisfactory analytical performance with
wide linear range, low detection limit and excellent speciﬁcity to
rutin detection.
The electrochemical method described here used a much
smaller plasma volume (10 μL) and had no complicated sample
extraction processes (without deproteinization), which was sui-
table for pharmacokinetic studies of rutin. The pharmacokinetic
parameters of rutin calculated were in agreement with these of
HPLC. This research provides a promising way for investigation of
the pharmacokinetics of rutin and for its utilization in clinical
practice.Acknowledgments
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